Start building today!
Experience the Find the courses and unlock the true potential
The Master of Philosophy (MPhil) offered through the John Curtin School of Medical Research (JCSMR) is a prestigious two-year, research-intensive postgraduate degree situated within one of Australia's most celebrated medical research institutions. Founded in 1948 and housed within the Australian National University in Canberra, JCSMR has a legacy of Nobel Prize-winning science and is renowned for pioneering work in immunology, cancer research, genomics, neuroscience, infectious diseases, and metabolic disorders. The MPhil is structured around a single, sustained, independent research project that culminates in a thesis of up to 60,000 words, assessed by no fewer than two external examiners of international standing. Students work under the direction of a supervisory panel of field experts, cultivating skills in literature analysis, project planning, laboratory techniques, data analysis, and research communication across three distinguished research divisions: Genome Sciences and Cancer, Immunology and Infectious Diseases, and Neuroscience.
This degree is designed for science graduates who wish to deepen their research expertise in fundamental medical science before pursuing a PhD or transitioning into a specialist industry role. The MPhil sits at AQF Level 9 and provides a dedicated pathway into national and international PhD programs or into careers within academia, industry, and government. Graduates are equipped to work across a broad range of sectors: academic and government research institutions (such as CSIRO, NHMRC-funded centres, and independent medical research institutes), the biotechnology and pharmaceutical industries, clinical research organisations, health policy agencies such as the Therapeutic Goods Administration, and hospital-based translational research units. Some alumni with prior medical qualifications go on to combine clinical research with medical practice or proceed to specialist training.
Australia's life sciences sector is experiencing remarkable growth, with the biotechnology market reaching $10.8 billion in 2024 and projected to expand at a compound annual growth rate of 17.5% through 2030. The federal government has committed over $20 billion through the Medical Research Future Fund and $500 million via the Biomedical Translation Fund to accelerate medical innovation and commercialisation, creating sustained demand for highly trained research scientists. The MedTech industry alone employs over 19,000 Australians across more than 500 companies, and there is a well-documented skills gap in areas including bioinformatics, molecular biology, clinical research, and regulatory affairs. An MPhil from a leading medical research school positions graduates at the forefront of this growth, offering the advanced technical and analytical skills that both industry and academia urgently require.
Beyond the immediate job market, studying an MPhil in medical research is an investment in long-term career potential. Salary data consistently shows that research scientists with master's-level qualifications earn significantly more than bachelor's graduates, and the degree serves as a recognised stepping stone to a PhD — the qualification held by the majority of senior medical research scientists in Australia. As artificial intelligence, genomics, gene editing (including CRISPR), and personalised medicine continue to reshape healthcare, professionals who combine deep scientific expertise with strong research methodology are in exceptional demand. Employers across pharma, biotech, hospital networks, and government increasingly seek 'hybrid professionals' who can bridge scientific innovation and real-world application — precisely the profile an MPhil in medical research cultivates.
To be considered for an MPhil in Medical Research at Australian universities, applicants typically must hold a four-year honours bachelor's degree (or equivalent) in a relevant scientific discipline — such as biomedical science, biochemistry, genetics, immunology, neuroscience, pharmacology, or medicine — with a strong academic result, generally a minimum weighted average of 70–75% or equivalent to Second Class Honours (Division A) or above. Some institutions also consider applicants holding a relevant master's degree with a substantial research component. In all cases, admission is competitive, and meeting minimum academic requirements does not guarantee entry. Admission is also subject to supervisory capacity, availability of suitable infrastructure, and approval from the relevant academic authority. Applicants must identify and secure the written support of an academic supervisor for their proposed research project prior to or as part of the application process.
All applicants must submit a current academic CV including qualifications, work experience, and any research publications, along with at least two academic referee reports. A research proposal or statement of research intent is commonly required, outlining the intended project, its significance, and its alignment with the host institution's research strengths. For international applicants, English language proficiency requirements must be met — typically an IELTS Academic score of at least 6.5 overall (with no band below 6.0), or equivalent in TOEFL, PTE Academic, or Cambridge Advanced English. Applicants who completed their prior degree entirely in English may be exempt. Candidates are also required to complete Research Integrity Training upon commencement, and many programs encourage participation in career development frameworks encompassing research training, teaching, industry engagement, and policy and governance skills.
This course may be offered in different study modes depending on the university, campus location, course structure and student type. Students should check the available delivery mode before applying, as not every study option is available at every institution.
On-campus study is the traditional mode of delivery where students attend classes, lectures, tutorials, workshops or seminars at the university campus. This option may suit students who prefer face-to-face learning, access to campus facilities, networking with classmates, practical workshops, group projects and direct engagement with academic staff.
Some universities may offer programs fully online or with online subject options. Online study can be attractive for students who need flexibility due to work, family, location or other commitments. Online study may suit domestic students, working professionals or students who want to study from outside Australia.
Hybrid or blended study usually combines online learning with some on-campus classes, workshops, intensive sessions or practical components. This mode may suit students who want flexibility but still want some face-to-face interaction. The exact structure varies between institutions.
Programs in Australia may have different intake structures depending on the university. The most common intake systems are semester, trimester and block mode.
Many Australian universities follow a two-semester academic calendar. The main intakes are commonly Semester 1 (around February or March) and Semester 2 (around July). Semester-based study usually allows students to complete a set number of subjects over approximately 12 to 14 weeks.
Some universities use a trimester system, which generally provides three study periods a year — around February/March, June/July and October/November. Trimester study may provide more flexibility and may help some students complete their course faster.
Some institutions may offer selected subjects or programs in block mode, where students focus on one subject at a time over a shorter, more intensive teaching period. Block mode may suit students who prefer concentrated learning or working professionals managing study around employment.
Some online or professionally focused programs may offer more frequent start dates or flexible entry points throughout the year. Students should not assume that every course has monthly or multiple intakes — availability depends on the institution, course structure and student type.
Graduates of an MPhil in Medical Research from JCSMR and comparable programs are positioned for a wide range of careers across academia, the biotechnology and pharmaceutical industries, clinical research organisations, government health agencies, and hospital-based research. The degree is widely recognised as an excellent foundation for progression to a PhD or direct entry into specialist research and science management roles. Australia's rapidly expanding life sciences sector — encompassing over 500 MedTech companies and a booming biotech market — creates diverse opportunities for MPhil graduates with advanced laboratory, analytical, and communication skills. Employers include CSIRO, NHMRC-funded medical research institutes, the Therapeutic Goods Administration, major pharmaceutical companies such as CSL, AstraZeneca, Pfizer, AbbVie, and Johnson & Johnson, as well as a growing ecosystem of Australian biotech startups in Melbourne, Sydney, Brisbane, and beyond.
Entry Level
Research Assistant / Graduate Scientist
Research Assistant, Junior Research Officer, Laboratory Technician, Graduate Scientist, Junior Clinical Trials Coordinator
Early Career
Research Officer / Associate Scientist
Research Officer, Associate Scientist, Clinical Research Associate, Regulatory Affairs Officer, Postdoctoral Research Fellow, Science Policy Officer
Mid-Level
Senior Scientist / Research Specialist
Senior Research Scientist, Biomedical Scientist, Senior Clinical Research Associate, Bioinformatics Specialist, Laboratory Manager, Medical Science Liaison
Senior Level
Principal Scientist / Research Manager
Principal Research Scientist, Group Leader, Clinical Trials Manager, Head of Research, Regulatory Affairs Manager, Senior Policy Adviser
Leadership
Director / Head / Chief Scientist
Director of Research, Head of Department, Chief Scientific Officer, Director of Clinical Development, Deputy Director of Medical Research Institute, Associate Professor / Professor
Salaries for medical research and biomedical science graduates in Australia vary by role, sector, specialisation, and experience level, with research-intensive and industry-facing positions generally offering the highest remuneration.
Melbourne
Melbourne is Australia's undisputed life sciences capital, home to the Melbourne Biomedical Hub in Parkville — the largest biomedical precinct in the Southern Hemisphere — housing over 40 hospitals, research institutes, and biotech companies including CSL, Mesoblast, and global pharma majors like Pfizer. Victoria's medtech sector benefits from substantial government investment and a thriving startup ecosystem, with a 34% increase in digital health startups in 2024, making it an outstanding city for MPhil graduates seeking industry and academic research careers.
Sydney
Sydney serves as Australia's financial and commercial capital and a premier hub for pharmaceutical companies, CROs (contract research organisations), and health technology firms, with the Macquarie Park Innovation District anchoring life science, medical devices, research, and innovation activity. Global companies including AbbVie, Johnson & Johnson, and IQVIA have a strong Sydney presence, offering MPhil graduates access to clinical research, regulatory affairs, and medical science liaison roles alongside strong university-affiliated research institutes.
Brisbane
Brisbane is rapidly developing as a biomedical and biotech hub, with the Boggo Road and Herston Health Precincts forming part of Queensland's 'knowledge corridor' — uniting world-class institutions including the Translational Research Institute, QIMR Berghofer, Princess Alexandra Hospital, CSIRO, and Vaxxas. A growing biotech startup ecosystem and strong university-affiliated research centres make Brisbane an increasingly attractive destination for aspiring medical researchers, with the added advantage of a lower cost of living than Sydney or Melbourne.
Perth
Perth is home to a growing biomedical research and biotechnology sector, with the Perth Biomedical Precinct receiving recent government funding commitments and the UWA and CSIRO Floreat Innovation Hub emerging as a significant research and development destination. Western Australia's strong mining sector also creates unique demand for biotechnology applications in genomics and environmental science, providing MPhil graduates with distinctive interdisciplinary opportunities alongside more traditional medical research roles.
Adelaide
Adelaide has a focused and well-supported medical biotechnology sector, with South Australia Government actively investing in health and medical research through institutions including the South Australian Health and Medical Research Institute (SAHMRI) and SA Pathology. The city offers a lower cost of living than eastern seaboard capitals, a collaborative research culture, and growing industry connections in medical devices, pharmaceutical manufacturing, and clinical trials — making it an attractive and affordable city for early-career research scientists.
Canberra
Canberra is the home of the John Curtin School of Medical Research itself and the natural base for MPhil students in this specific program, offering direct access to ANU's world-class research infrastructure spanning biomolecular screening, genomics, advanced microscopy, and neuroscience. As the national capital, Canberra also provides unparalleled proximity to federal government health agencies including the NHMRC, TGA, and Department of Health, opening career pathways in health policy, science advisory roles, and regulatory affairs for graduates who wish to shape Australia's research and health landscape.
Before choosing a course, students should compare:
International students who want to study in Australia should also consider additional requirements before applying.
Join successful graduates
Students Helped
Application Processed
Listed Universities
Listed Courses
